Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization

Archives of Internal Medicine
David S BattlemanHoward T Thaler

Abstract

To measure quality-of-care variables relevant to the treatment of community-acquired pneumonia and to determine their relative contribution to variation in length of hospital stay (LOS). One hundred cases of pneumonia requiring hospitalization from each of 7 institutions (2 community and 5 university teaching hospitals) were randomly selected (total sample, 700 cases). Demographic and clinical variables were abstracted using a standardized data instrument. Three quality-of-care measures were analyzed: (1) site of initial antibiotic treatment (emergency department vs floor), (2) door-to-needle time, and (3) appropriateness of antibiotic selection. Appropriate antibiotic selection was defined by the 1998 Infectious Disease Society of America guidelines for the treatment of hospitalized pneumonia cases. Regression modeling was used to determine associations between LOS and our quality-of-care (process) variables. The mean +/- SD LOS for this sample was 7.0 +/- 4.1 days. Prolonged LOS, defined as greater than or equal to the 75th percentile of the LOS distribution, was the dependent variable in our regression analysis and was greater than or equal to 9.0 days. After clinical and demographic variables were adjusted for, logistic reg...Continue Reading

Citations

Dec 20, 2003·Lancet·Thomas M File
Nov 22, 2013·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Hironori UematsuHideo Yasunaga
Jun 21, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Helen L RobinsonMichael Whitby
Feb 5, 2004·Postgraduate Medical Journal·A KinderP Sheldon
Dec 13, 2006·BMJ : British Medical Journal·Graham D Mills, Richard Laing
Nov 28, 2007·BMC Cardiovascular Disorders·Richard J CarrollAudrey Westbrook
Mar 25, 2008·Therapeutics and Clinical Risk Management·Anita G Carrie, Thomas J Marrie
Mar 13, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A H W BrunsA I M Hoepelman
Jan 1, 2010·International Journal of Emergency Medicine·Charlotte F J van TuijnSuzanne E Geerlings
Mar 19, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Thomas BewickWei Shen Lim
Mar 31, 2006·International Journal of Technology Assessment in Health Care·Marisa BaréMaria José Gil Egea
Dec 7, 2010·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Kylie A McIntoshSusan E Tett
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN Infectious Diseases Society of America
Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan D TiceUNKNOWN IDSA
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M MusherAnna Wanahita
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A SchoutenR P T M Grol
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M BodíUNKNOWN Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Nov 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale W BratzlerWato Nsa
Aug 29, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helio S SaderRonald N Jones
Jun 7, 2005·American Journal of Respiratory and Critical Care Medicine·Rosario MenéndezUNKNOWN NEUMOFAIL Group
Jan 21, 2016·Expert Review of Respiratory Medicine·Jordi Rello, Antonio Perez
Mar 15, 2013·The Journal of Emergency Medicine·Andrew SucovSteven E Reinert
Oct 30, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Junghyun KimDeog Kyeom Kim
Oct 14, 2008·International Journal of Antimicrobial Agents·Robert G Masterton
Oct 1, 2008·The American Journal of Medicine·Alberto CapelasteguiAmaia Bilbao
Feb 26, 2008·Infectious Disease Clinics of North America·Gregory J MoranFredrick M Abrahamian
Feb 14, 2006·The Medical Clinics of North America·Joseph R Shiber, Jose Santana
Sep 16, 2003·Journal of Clinical Pharmacology·Guy W AmsdenPatrick W Johnson
Jun 2, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·David J Serisier, Simon D Bowler
May 23, 2007·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Kirsten SchafferLynda Fenelon
Jan 24, 2008·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Demetrios N KyriacouJames G Adams
Nov 16, 2004·The American Journal of Medicine·Eric M MortensenJacqueline Pugh
Jul 11, 2006·Archivos de bronconeumología·Alberto CapelasteguiAmaia Bilbao
Oct 19, 2006·The Journal of Emergency Medicine·Merrill A Cohen, Gwendolyn M Lewis
Nov 24, 2004·Infectious Disease Clinics of North America·Nathan C Dean, Kim A Bateman
Sep 27, 2006·The American Journal of Medicine·Eric M MortensenJacqueline A Pugh
Mar 23, 2007·Expert Opinion on Pharmacotherapy·Lilibeth Pineda, Ali A El Solh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.